InsidersTradesSigma
Follow the CTQ stock price and the full management transaction log of the company, a listed issuer based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Healthcare & Pharma sector, CTQ has recorded 4 reports. Market capitalisation: €8.1m. The latest transaction was filed on 2 June 2026 (Other). Among the most active insiders: NFPFRN (if applicable). The full history is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
20Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,325 of 28,832 companies
24.1
score / 100
Value8
Quality41
FCF yld-28%
Earn yld-34%
EV/EBITDA·
ROE-11%
Gross mgn100%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 June 2026
Declarations4 total
ShareASXASX:2924-03096681-2A1675260
ShareASXASX:2924-03096680-2A1675259
ShareASXASX:2924-03090515-2A1672263
ShareASXASX:2924-03089466-2A1671761
4 of 4 declarations
About CTQ
CTQ is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market. It focuses on developing innovative solutions to enhance healthcare.
